SCHEMBL21028141

SCHEMBL21028141

CCc1ccc(S(=O)(=O)N[C@@H](C)C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.42
CA2 P00918 2/20 0.40
CA1 P00915 1/20 0.40
MMP7 P09237 2/20 0.39
FFAR4 Q5NUL3 1/20 0.39
CCR2 P41597 4/20 0.39
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEP1B Q16820 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KIF11 P52732 1/20 0.36
ADAMTS4 O75173 1/20 0.36
MMP13 P45452 1/20 0.36
NR3C1 P04150 1/20 0.36
PGR P06401 1/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21028377 0.88 RORC (0.41) RORCCA2CA1MMP7CCR2
SCHEMBL16852788 0.83 RORC (0.41) RORCCA2CA1MMP7FFAR4
SCHEMBL21028378 0.82 RORC (0.45) RORCCA2CA1MMP7CCR2
SCHEMBL17709999 0.82 RORC (0.41) RORCCA2CA1MMP7FFAR4
SCHEMBL17710000 0.82 RORC (0.41) RORCCA2CA1MMP7FFAR4
SCHEMBL21026345 0.80 RORC (0.42) RORCCA2CA1FFAR4NPSR1
SCHEMBL21028344 0.79 ALDH1A1 (0.39) RORCCA2CA1NPSR1MEN1
SCHEMBL12560322 0.76 PTGDR2 (0.45) RORCFFAR4CCR2KIF11
SCHEMBL12875596 0.76 KIF11 (0.49) FFAR4CCR2KIF11
SCHEMBL1762386 0.74 FFAR4 (0.39) FFAR4CCR2POLBL3MBTL1MEP1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC RORC 3/4885CA2 343/4885CA1 687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.